RxDoctor Payments Data

Garrick Greear, MD

Urology · Longmont, CONPI 1164873816

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,837 of the $62,077 with a category attached, or 81.9%. Boston Scientific accounts for 86.9% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2021 at $50,541 and has fallen 97.5% since, to $1,243 in 2025. Among urology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,077in general payments, 2019–2025

Across 229 payments — averaging $271.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$54K
  • Coloplast$5K
  • Teleflex LLC$972
  • Endo Pharmaceuticals Inc.$345
  • Sumitomo Pharma America, Inc.$273
  • Procept Biorobotics Corporation$248
  • plus $2K from 31 others

What the payments were for

  • Grants$50,83782%
  • Travel & lodging$3,8966%
  • Food & beverage$7,34412%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,077 in reported general payments places this provider in the 95th percentile of 225 urology providers in Colorado.

See all urology providers in Colorado

Medicare billing

Part B allowed, 2024
$111,467
Medicare patients
277
Services billed
2,498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron42$38,218
Testosterone28$4,938
Testosterone Cypionate100$4,285
Tamsulosin Hcl201$3,705
Finasteride112$1,239
Trospium Chloride15$1,202
Solifenacin Succinate27$675
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst16$318
Cefadroxil16$92
Oxycodone Hcl13$40

Paid to pharmacies, not to this prescriber.

Other urology in Longmont

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →